Developer docs
API playgroundTry for free, no card

Search company profiles

Novocare

Full company profile

uuid0004515

Namestring
Novocare
Websiteurl
novocare.co
Company typeenum
Private
Founded yearint
2012
Descriptiontext

NovoCare is a proprietary direct-to-patient (DTP) healthcare pharmacy platform operated by Novo Nordisk (NYSE: NVO), structured as a manufacturer-owned channel that delivers prescription medications directly to patients without routing through traditional retail pharmacies. The platform serves patients requiring ongoing prescription medications, particularly those on specialty drugs or chronic disease management therapies drawn from Novo Nordisk's portfolio, including diabetes and obesity treatments. Functionally, it consolidates benefit verification, prior authorization automation, telehealth consultation, and prescription fulfillment into a single end-to-end workflow, with stated objectives of improving first-fill medication adherence rates and capturing real-world outcomes data that would otherwise be intermediated by third-party retail pharmacies.

The underlying technology is a vertically integrated pharmacy operations platform rather than a standalone software product; no proprietary algorithms, AI/ML components, or technical patents are disclosed. The platform's value proposition is fundamentally structural: by owning the last-mile distribution channel, Novo Nordisk captures the full patient relationship, retains transaction economics, and accumulates outcomes data that strengthens its competitive position in chronic disease therapeutics. Revenue mechanics operate on a transaction-fee model tied to pharmaceutical fulfillment through the DTP channel, though no publicly disclosed pricing or per-prescription economics are available.

As a captive strategic initiative rather than an independently capitalized entity, NovoCare has no separate funding rounds, third-party ownership, or standalone management team disclosed. Its strategic significance lies in representing Novo Nordisk's shift toward manufacturer-controlled patient engagement, a model increasingly relevant in the GLP-1 era where direct patient relationships, adherence data, and benefit navigation are competitively differentiating.

Short descriptiontext

Novo Nordisk's proprietary direct-to-patient pharmacy platform that fulfills prescriptions, automates benefit verification and prior authorization, and integrates telehealth for patients requiring specialty and chronic disease medications from Novo Nordisk's portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersShenzhen, China
HQ citystring
Shenzhen
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
medical device development, medical equipment research, healthcare product design, medical technology R&D, clinical device engineering
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Health Services8000
Product category
Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical fulfillment through proprietary DTP channel
TypeTransaction Fee
Description

NovoCare serves as Novo Nordisk's proprietary direct-to-patient pharmacy platform, enabling the pharmaceutical manufacturer to capture revenue from prescription fulfillment while controlling patient relationships, gathering outcomes data, and improving first-fill rates without routing through traditional retail pharmacies.

develophealth.ai
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Novocare is a medical equipment research and development company that designs and develops medical devices. The firm is headquartered in Shenzhen, China, and was founded in 2012. It employs 51–100 staff and operates as a privately held for-profit entity, with product and customer specifics not publicly disclosed in available sources.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Improved first-fill rates compared to traditional pharmacy routing
Product and service1 record
1Medical equipment R&D services
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Novocare

Medical Devicesnovocare.co

Novo Nordisk's proprietary direct-to-patient pharmacy platform that fulfills prescriptions, automates benefit verification and prior authorization, and integrates telehealth for patients requiring specialty and chronic disease medications from Novo Nordisk's portfolio.

What Novocare does

NovoCare is a proprietary direct-to-patient (DTP) healthcare pharmacy platform operated by Novo Nordisk (NYSE: NVO), structured as a manufacturer-owned channel that delivers prescription medications directly to patients without routing through traditional retail pharmacies. The platform serves patients requiring ongoing prescription medications, particularly those on specialty drugs or chronic disease management therapies drawn from Novo Nordisk's portfolio, including diabetes and obesity treatments. Functionally, it consolidates benefit verification, prior authorization automation, telehealth consultation, and prescription fulfillment into a single end-to-end workflow, with stated objectives of improving first-fill medication adherence rates and capturing real-world outcomes data that would otherwise be intermediated by third-party retail pharmacies.

The underlying technology is a vertically integrated pharmacy operations platform rather than a standalone software product; no proprietary algorithms, AI/ML components, or technical patents are disclosed. The platform's value proposition is fundamentally structural: by owning the last-mile distribution channel, Novo Nordisk captures the full patient relationship, retains transaction economics, and accumulates outcomes data that strengthens its competitive position in chronic disease therapeutics. Revenue mechanics operate on a transaction-fee model tied to pharmaceutical fulfillment through the DTP channel, though no publicly disclosed pricing or per-prescription economics are available.

As a captive strategic initiative rather than an independently capitalized entity, NovoCare has no separate funding rounds, third-party ownership, or standalone management team disclosed. Its strategic significance lies in representing Novo Nordisk's shift toward manufacturer-controlled patient engagement, a model increasingly relevant in the GLP-1 era where direct patient relationships, adherence data, and benefit navigation are competitively differentiating.

Novocare firmographics

Firmographics
Name
Novocare
Website
https://novocare.co
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Novo Nordisk's proprietary direct-to-patient pharmacy platform that fulfills prescriptions, automates benefit verification and prior authorization, and integrates telehealth for patients requiring specialty and chronic disease medications from Novo Nordisk's portfolio.
Ownership category
akta.pro rank

Where Novocare is headquartered

Location

Headquarters

HQ city
Shenzhen
HQ country
China
HQ region
Asia

Markets served

Novocare business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations

Revenue model

  1. Pharmaceutical fulfillment through proprietary DTP channel: NovoCare serves as Novo Nordisk's proprietary direct-to-patient pharmacy platform, enabling the pharmaceutical manufacturer to capture revenue from prescription fulfillment while controlling patient relationships, gathering outcomes data, and improving first-fill rates without routing through traditional retail pharmacies.

Go-to-market motion1 record

Distribution channels1 record

Novocare product offering

Product offering

Core offering

Novocare is a medical equipment research and development company that designs and develops medical devices. The firm is headquartered in Shenzhen, China, and was founded in 2012. It employs 51–100 staff and operates as a privately held for-profit entity, with product and customer specifics not publicly disclosed in available sources.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical equipment R&D services

Quantifiable outcome

  • Improved first-fill rates compared to traditional pharmacy routing

Companies that use Novocare

Customer profile

Segments1 record

Ideal customer profiles1 record

Novocare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Novocare partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights4 records

Novocare competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat3 records

Key risks6 records

Key highlights3 records

Customer concentration

Novocare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Novocare leadership team

Management profile

Number of profiles

Profiles1 record

Novocare funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Novocare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novocare

What does Novocare do?

Novocare is a medical equipment research and development company that designs and develops medical devices. The firm is headquartered in Shenzhen, China, and was founded in 2012. It employs 51–100 staff and operates as a privately held for-profit entity, with product and customer specifics not publicly disclosed in available sources.

Is Novocare a public or private company?

Novocare is a private company. It is classified as venture growth investor backed and is currently operating.

When was Novocare founded?

Novocare was founded in 2012. It employs 51 to 100 people.

Where is Novocare based?

Novocare is headquartered in Shenzhen, China, in the Asia region.

How does Novocare make money?

One revenue line is on record: pharmaceutical fulfillment through proprietary DTP channel.

Does Novocare have an API?

No public API is recorded for Novocare.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales